All Stories

  1. Therapeutic applications of human umbilical cord-derived mesenchymal stem cell secretome in chronic inflammatory diseases and cancer: A recent update
  2. Editorial: Mesenchymal stem cells and derived extracellular vesicles as next-generation biological drugs for tissue regeneration
  3. Exploring the Role of Gut Microbiota in Diabetes and Colorectal Cancer
  4. MicroRNAs and Cancer Stem Cells: Mechanisms and Their Role in Cancer
  5. An Overview of MicroRNA Biology: From Biogenesis to Therapeutic Implications
  6. Endoplasmic reticulum stress and exosomes secretion in the pathogenesis of inflammatory bowel disease: a concise summary of research findings
  7. Trimethylamine N-Oxide (TMAO) and cancer risk: Insights into a possible link
  8. A review of short-Chain fatty acids in gut and skin: Possible implications in skin aging
  9. Mesenchymal stromal cell-laden hydrogels in tissue regeneration: insights from preclinical and clinical research
  10. 4‐Phenylbutyric Acid Reduces the Proliferation in Colon Cancer Cell Lines Through Modulating the Cell Cycle Regulatory Genes: An In Silico and In Vitro Approach
  11. A neutral 1D polymeric Hg(II) complex harvested from 9-butyl adenine: Synthesis, crystal structure, Hirshfeld surface, DFT optimization, and anti-microbial activities
  12. A study on antibacterial activities of RHRet: a formulation of plant-derived compounds
  13. Evaluating the expression level of serum Interleukin-2, lipoarabinomannan and circulating MicroRNA-29a as diagnostic biomarkers for pulmonary and extra-pulmonary tuberculosis: a pilot study
  14. A review on mesenchymal stem cells and their secretome in hepatocellular carcinogenesis and its related signaling pathways: recent update
  15. A review of circular RNAs in colorectal cancer: insights into biomarker discovery and therapeutic targeting
  16. Comparison of Fibrin Characteristics and Cellular Contents of Injectable Platelet-rich Fibrin Enriched Bone Block (“Sticky Bone”) Prepared Using Novel and Traditional Protocols – An In vitro Study
  17. Colorectal Cancer Diagnosis
  18. Pharmacological potential of natural chalcones: a recent studies and future perspective
  19. A Study on the Potential of Curcumin in Proliferation and Apoptosis of SW480 and SW620 Colon Cancer Cell Lines
  20. Klotho protein: a multifaceted regulator in aging and cancer dynamics
  21. Synthesis, characterization, DFT optimization, and antimicrobial activities of Co(III) and Cd(II) complexes derived from pyridyl Schiff base ligand N -2-(6-methylpyridyl)-2-hydroxy-1-naphthaldimine
  22. A brief review of Lynch syndrome: understanding the dual cancer risk between endometrial and colorectal cancer
  23. Mitochondrial microRNAs (mitomiRs) as emerging biomarkers and therapeutic targets for chronic human diseases
  24. An overview of potential of natural compounds to regulate epigenetic modifications in colorectal cancer: a recent update
  25. MicroRNA-122 overexpression suppresses the colon cancer cell proliferation by downregulating the astrocyte elevated gene-1/metadherin oncoprotein
  26. Recent advances in nanomedicine for the diagnosis and therapy of thyroid disorders
  27. Targeting Cytokine-Mediated Inflammation in Brain Disorders: Developing New Treatment Strategies
  28. Unraveling the mechanism of microRNA-134 in colon cancer progression: Targeting KRAS and PIK3CA for cell cycle control and histone deacetylase regulation
  29. Advancements in immunotherapy for colorectal cancer treatment: a comprehensive review of strategies, challenges, and future prospective
  30. A pilot study on the efficacy of a telomerase activator in regulating the proliferation of A375 skin cancer cell line
  31. Role of 4-Phenylbutyric Acid in DNA and Protein Binding and its Functional Analysis
  32. Roles of the gut microbiota in human neurodevelopment and adult brain disorders
  33. Targeting Cytokine-Mediated Inflammation in Brain Disorders: Developing New Treatment Strategies
  34. The cardioprotective effects of Fruitflow® against Doxorubicin-induced toxicity in rat cardiomyoblast cells H9c2 (2−1) and high-fat diet-induced dyslipidemia and pathological alteration in cardiac tissue of Wistar Albino rats
  35. Plant Derived Bioactive Compounds in Human Health and Disease
  36. The Potential of Rutin and Curcumin in Inducing Differentiation of Mouse C3H10 Cells Towards a Neuronal-Like Lineage
  37. Current Insights into Molecular Mechanisms and Potential Biomarkers for Treating Radiation-Induced Liver Damage
  38. Biomarkers in diagnosing and therapeutic monitoring of tuberculosis: a review
  39. A brief review on recent advances in diagnostic and therapeutic applications of extracellular vesicles in cardiovascular disease
  40. A concise review of the impact of groundwater pollution in coastal regions on human gut microbiome composition and its effect on human health
  41. AEG-1 as a Novel Therapeutic Target in Colon Cancer: A Study from Silencing AEG-1 in BALB/c Mice to Large Data Analysis
  42. Mitochondrial dysfunction and its association with age-related disorders
  43. A Review on the Efficacy of Plant-derived Bio-active Compounds Curcumin and Aged Garlic Extract in Modulating Cancer and Age-related Diseases
  44. Exploring the Relationship Between Diet, Lifestyle and Gut Microbiome in Colorectal Cancer Development: A Recent Update
  45. Evaluation of the synergistic effects of curcumin-resveratrol co-loaded biogenic silica on colorectal cancer cells
  46. An Updated Review on Molecular Biomarkers in Diagnosis and Therapy of Colorectal Cancer
  47. Evaluating the Anti-proliferative and Apoptotic Role of Atrial Natriuretic Peptide in Colon Cancer Cell Lines
  48. Understanding the molecular mechanism responsible for developing therapeutic radiation-induced radioresistance of rectal cancer and improving the clinical outcomes of radiotherapy - A review
  49. RNA-based Therapies for Aging and Cancer, What Known so Far?
  50. A Review on Emerging Techniques for Diagnosis of Colorectal Cancer
  51. Exploring the Therapeutic Significance of microRNAs and lncRNAs in Kidney Diseases
  52. Current Technologies and Future Perspectives in Immunotherapy towards a Clinical Oncology Approach
  53. Effect of prebiotics, probiotics, and synbiotics on gut microbiome in diabetes among coastal communities
  54. Microbiota and Dietary Mediators in Colon Cancer Prevention and Treatment
  55. Small Molecules for Cancer Treatment
  56. Gut Microbiome and Brain Ageing
  57. Impacts of gut microbiota alteration on age-related chronic liver diseases
  58. Neuroprotective Effects of Phytochemicals in Brain Ageing
  59. Cancer Stem Cells and Signaling Pathways
  60. Stem Cells and Signaling Pathways
  61. Current Understating of Gut Microbiome Alterations and Therapeutic Approaches for Improving Human Health
  62. Editorial: Therapeutic potential of mesenchymal stem cells in organ and tissue regeneration
  63. The Regulatory Role of MicroRNAs in Obesity and Obesity-Derived Ailments
  64. BMAP-27 Peptide Reduces Proliferation and Increases Apoptosis in Primary and Metastatic Colon Cancer Cell Lines
  65. Fatty Acids and their Proteins in Adipose Tissue Inflammation
  66. Association of MicroRNA-652 Expression with Radiation Response of Colorectal Cancer: A Study from Rectal Cancer Patients in a Swedish Trial of Preoperative Radiotherapy
  67. A brief overview of SARS-CoV-2 infection and its management strategies: a recent update
  68. Healthy Aging: Perseverance to Well Being
  69. Anti-cancer Properties of Dietary Supplement CELNORM against Colon and Lung Cancer: An in vitro preliminary study
  70. Endothelial dysfunction, platelet hyperactivity, hypertension, and the metabolic syndrome: molecular insights and combating strategies
  71. Applications of nanotechnologies for miRNA-based cancer therapeutics: current advances and future perspectives
  72. The Emerging Role of Senotherapy in Cancer: A Comprehensive Review
  73. Functional Foods: A Promising Strategy for Restoring Gut Microbiota Diversity Impacted by SARS-CoV-2 Variants
  74. Role of Interleukins in Inflammation-Mediated Tumor Immune Microenvironment Modulation in Colorectal Cancer Pathogenesis
  75. The Emerging Role of Curcumin in Inducing Neuronal Trans-differentiation of Mesenchymal Stem Cells: a Review
  76. A mini-review to delineate the different roles of stem cells and Wnt signalling pathways in governing transdifferentiation towards neuronal lineage.
  77. A concise review on miRNAs as regulators of colon cancer stem cells and associated signalling pathways
  78. An Updated Review on the Role of Nanoformulated Phytochemicals in Colorectal Cancer
  79. The regulatory role of microRNAs in common eye diseases: A brief review
  80. Epigenetic perspectives associated with COVID-19 infection and related cytokine storm: an updated review
  81. An Updated Review on Recent Advances in the Usage of Novel Therapeutic Peptides for Breast Cancer Treatment
  82. Natural Compounds as Integrative Therapy for Liver Protection against Inflammatory and Carcinogenic Mechanisms: From Induction to Molecular Biology Advancement
  83. Regulatory mechanisms of microRNAs in endocrine disorders and their therapeutic potential
  84. A Comprehensive Study on the Anti-cancer Effects of Quercetin and Its Epigenetic Modifications in Arresting Progression of Colon Cancer Cell Proliferation
  85. Signaling Pathways in Trans-differentiation of Mesenchymal Stem Cells: Recent Advances
  86. A Study on the Role of piRNAs in Cancer Epigenetics
  87. Advancements in stem cell-based therapeutics in phospholipase A2-dependent colorectal cancer
  88. Evidence-based Functional Foods for Prevention of Age-related Diseases
  89. Handbook of Animal Models and its Uses in Cancer Research
  90. MicroRNAs and long non-coding RNAs in pancreatic cancer: From epigenetics to potential clinical applications
  91. Recent Advancements, Limitations, and Future Perspectives of the use of Personalized Medicine in Treatment of Colon Cancer
  92. A study on total RNA including microRNA isolation from cell lines by different cost effective methods
  93. A Brief Overview of Telomeres and Telomerase in Aging and Cancer
  94. RNA-Interference-Mediated miR-122-Based Gene Regulation in Colon Cancer, a Structural In Silico Analysis
  95. Exploring dithiolate-amine binary ligand systems for the supramolecular assemblies of Ni(II) coordination compounds: Crystal structures, theoretical studies, cytotoxicity studies, and molecular docking studies
  96. A Concise Review on the Role of Natural and Synthetically Derived Peptides in Colorectal Cancer
  97. Molecular Characterization of Primary and Metastatic Colon Cancer Cells to Identify Therapeutic Targets with Natural Compounds
  98. Anti-inflammatory effect of Phytomarine R-L compound against lipopolysaccharide- induced pulmonary injury in BALB/c mice
  99. Rubus ellipticus fruits extract-mediated cuprous oxide nanoparticles: in vitro antioxidant, antimicrobial, and toxicity study
  100. Maternal Obesity and Gut Microbiota Are Associated with Fetal Brain Development
  101. Correction to: Wnt Signalling Inhibitors Potently Drive Trans-differentiation Potential of Mesenchymal Stem Cells Towards Neuronal Lineage
  102. Bioactive food components and their inhibitory actions in multiple platelet pathways
  103. Recent insights into the microRNA and long non-coding RNA-mediated regulation of stem cell populations
  104. MicroRNA-mediated regulation of key signaling pathways in hepatocellular carcinoma: A mechanistic insight
  105. Can plant-derived anti-HIV compounds be used in COVID-19 cases?
  106. Plant-derived bioactive compounds in colon cancer treatment: An updated review
  107. Wnt Signalling Inhibitors Potently Drive Trans-differentiation Potential of Mesenchymal Stem Cells Towards Neuronal Lineage
  108. Epigenetic perspectives associated with COVID-19 infection and related cytokine storm: An updated review
  109. A Comprehensive Cancer-Associated MicroRNA Expression Profiling and Proteomic Analysis of Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes
  110. Functional Implications and Clinical Potential of MicroRNAs in Irritable Bowel Syndrome: A Concise Review
  111. Tumor Suppressor microRNAs in Gastrointestinal Cancers: A Mini-Review
  112. Dietary Fats and the Gut Microbiota: Their impacts on lipid-induced metabolic syndrome
  113. Role of ER Stress Mediated Unfolded Protein Responses and ER Stress Inhibitors in the Pathogenesis of Inflammatory Bowel Disease
  114. Essentiality, relevance, and efficacy of adjuvant/combinational therapy in the management of thyroid dysfunctions
  115. A Brief Review on the Regulatory Roles of MicroRNAs in Cystic Diseases and Their Use as Potential Biomarkers
  116. Cytoplasmic fatty acid-binding proteins in metabolic diseases and cancers
  117. Nanoparticles for Tissue Engineering: Type, Properties, and Characterization
  118. The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review
  119. Therapeutic Strategies Targeting Wnt/β-Catenin Signaling Pathway in Stem Cells for ROS-Induced Cancer Progression
  120. Therapeutic Strategies Targeting Wnt/β-Catenin Signaling Pathway in Stem Cells for ROS-Induced Cancer Progression
  121. A comprehensive cancer-associated microRNA expression profiling and proteomic analysis of human umbilical cord mesenchymal stem cell derived exosomes.
  122. Oxidative Stress and Cellular Senescence: The Key Tumor-promoting Factors in Colon Cancer and Beneficial Effects of Polyphenols in Colon Cancer Prevention
  123. Aging in HIV: Can natural compounds beneficially affect its higher progression?
  124. Association of microRNA-652 Expression with Radiation Response of Colorectal Cancer: A Study from Rectal Cancer Patients in a Swedish Trial of Preoperative Radiotherapy to Public Data Analysis and in Vitro Investigation
  125. Current Understanding of Epigenetics Driven Therapeutic Strategies in Colorectal Cancer Management
  126. Current understanding of the mesenchymal stem cell-derived exosomes in cancer and aging
  127. A review on interplay between small RNAs and oxidative stress in cancer progression
  128. Is Biotechnological Next-Generation Therapeutics Promising Enough in Clinical Development to Treat Advanced Colon Cancer?
  129. Vitagenic Effect of Specific Bioactive Fractions of Rhodiola with Trachurus sp. Extract Against Oxidative Stress-Induced Aging in Human Amnion Derived Epithelial Cell Line: In View of a Novel Senolytic
  130. Beyond Physical Exercise: The Role of Nutrition, Gut Microbiota and Nutraceutical Supplementation in Reducing Age-Related Sarcopenia
  131. Maternal Supply of Both Arachidonic and Docosahexaenoic Acids Is Required for Optimal Neurodevelopment
  132. Emerging Role and Clinicopathological Significance of AEG-1 in Different Cancer Types: A Concise Review
  133. In silico analysis and prediction of transcription factors of the proteins interacting with astrocyte elevated gene-1
  134. Over-Expression of MicroRNA-122 Inhibits Proliferation and Induces Apoptosis in Colon Cancer Cells
  135. A Review of AEG-1 Oncogene Regulating MicroRNA Expression in Colon Cancer Progression
  136. Emerging Importance of microRNA in Early Detection of Colorectal Cancer
  137. Silencing of Astrocyte Elevated Gene-1 (AEG-1) inhibits the proliferative and invasive potential through interaction with Exostosin-1 (EXT-1) in primary and metastatic colon cancer cells
  138. Front Matter
  139. Sources, isolation strategies and therapeutic outcome of exosomes at a glance
  140. Conditioned medium from the human umbilical cord-mesenchymal stem cells stimulate the proliferation of human keratinocytes
  141. Antiproliferative effects of combinational therapy of Lycopodium clavatum and quercetin in colon cancer cells
  142. Cancer Stem Cells: New Horizons in Cancer Therapies
  143. Wnt signaling regulates the proliferation potential and lineage commitment of human umbilical cord derived mesenchymal stem cells
  144. Inflammatory Bowel Disease Therapies Adversely Affect Fertility in Men- A Systematic Review and Meta-analysis
  145. Targeting Wnt Signaling through Small molecules in Governing Stem Cell Fate and Diseases
  146. A Review on Theragnostic Applications of Micrornas and Long Non- Coding RNAs in Colorectal Cancer
  147. Role of Tumor Specific niche in Colon Cancer Progression and Emerging Therapies by Targeting Tumor Microenvironment
  148. Benefits of aged garlic extract in modulating toxicity biomarkers against p-dimethylaminoazobenzene and phenobarbital induced liver damage in Rattus norvegicus
  149. Health hazards of nanoparticles: understanding the toxicity mechanism of nanosized ZnO in cosmetic products
  150. Evaluation of potential anti-cancer activity of cationic liposomal nanoformulated Lycopodium clavatum in colon cancer cells
  151. Significant expression of tafazzin (TAZ) protein in colon cancer cells and its downregulation by radiation
  152. Review on comparative efficacy of bevacizumab, panitumumab and cetuximab antibody therapy with combination of FOLFOX-4 in KRAS-mutated colorectal cancer patients
  153. Strategies for targeted drug delivery in treatment of colon cancer: current trends and future perspectives
  154. MiR-155 modulates the inflammatory phenotype of intestinal myofibroblasts by targeting SOCS1 in ulcerative colitis
  155. Umbilical cord mesenchymal stem cells modulate dextran sulfate sodium induced acute colitis in immunodeficient mice
  156. Is chronic feeding of low dose alcohol hepatotoxic or genotoxic?: A time course study in mice
  157. Increased antibody response to microbial antigens in patients with Crohn's disease and their unaffected first-degree relatives
  158. Systemic administration of a novel human umbilical cord mesenchymal stem cells population accelerates the resolution of acute liver injury
  159. An initial report on the efficacy of a millesimal potency Arsenicum Album LM 0/3 in ameliorating arsenic toxicity in humans living in a high-risk arsenic village
  160. A Follow-Up Study on the Efficacy of the Homeopathic RemedyArsenicum albumin Volunteers Living in High Risk Arsenic Contaminated Areas
  161. Antioxidative potential of a combined therapy of anti TNFα and Zn acetate in experimental colitis
  162. Efficacy of ethanolic spore extract of Lycopodium clavatum in reducing induced hepatotoxicity and genotoxicity in mice
  163. Chelidonium majus 30C and 200C in induced hepato-toxicity in rats
  164. Can Homeopathy Bring Additional Benefits to Thalassemic Patients on Hydroxyurea Therapy? Encouraging Results of a Preliminary Study
  165. A synthetic coumarin (4-Methyl-7 hydroxy coumarin) has anti-cancer potentials against DMBA-induced skin cancer in mice
  166. Crude Extract of Turmeric Reduces Hepato-Toxicity and Oxidative Stress in Rats Chronically Fed Carcinogens
  167. Homeopathic remedy for arsenic toxicity?: Evidence-based findings from a randomized placebo-controlled double blind human trial
  168. Supportive Evidence for the Anticancerous Potential of Alternative Medicine against Hepatocarcinogenesis in Mice
  169. Can Administration of Potentized Homeopathic Remedy,Arsenicum Album, Alter Antinuclear Antibody (ANA) Titer in People Living in High-Risk Arsenic Contaminated Areas? I. A Correlation with Certain Hematological Parameters
  170. Can Homeopathic Arsenic Remedy Combat Arsenic Poisoning in Humans Exposed to Groundwater Arsenic Contamination?: A Preliminary Report on First Human Trial
  171. Topology Scanning and Putative Three-Dimensional Structure of the Extracellular Binding Domains of the Apical Sodium-Dependent Bile Acid Transporter (SLC10A2)†